Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,762 across all filing types
Latest filing 2024-05-24 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Dividend Updates
Regulatory Filings
2024-05-24 English
Date of payment of final dividend for the year 2023-24
Regulatory Filings
2024-05-24 English
Dividend updates
Regulatory Filings
2024-05-24 English
Record Date
Notice of Dividend Amount Classification · 95% confidence The document is a short notice addressed to the stock exchange regarding the fixing of a record date for determining shareholders entitled to receive the final dividend for the fiscal year 2023-24. It references Regulation 42 of the SEBI Listing Regulations, which pertains to disclosure requirements related to record dates for dividends. The document does not contain any financial statements, detailed financial data, or comprehensive report content. It is essentially an announcement about the dividend record date, which aligns with the category of Notice of Dividend Amount filings. Although it does not specify the dividend amount, the primary purpose is to inform about the record date for dividend entitlement, which fits best under the Notice of Dividend Amount category rather than a full dividend declaration or other report types. The document length is short (1687 characters), and it is not a report publication announcement or certification. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2024-05-24 English
Record date intimation for Final Dividend for the year 2023-24
Notice of Dividend Amount Classification · 95% confidence The document is a short notice dated 24th May 2024 from Torrent Pharmaceuticals Limited addressed to the stock exchange. It announces the Record Date for determining shareholders entitled to receive the final dividend for the fiscal year 2023-24. The document references Regulation 42 of the SEBI Listing Regulations, which pertains to dividend record dates. The content is an announcement about dividend-related dates and does not contain financial statements or detailed dividend amounts. It is not a full dividend declaration but an intimation of the record date for dividend entitlement. Given the short length (1685 characters) and the nature of the content, this fits best under the category of Notice of Dividend Amount (DIV), as it relates to dividend payment logistics rather than a full dividend declaration or other report types.
2024-05-24 English
Raising of funds
Regulatory Filings
2024-05-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.